AAAAAA

   
Results: 1-10 |
Results: 10
Impact of zidovudine-based triple combination therapy on an AIDS Drug Assistance Program
Authors: Mauskopf, JA Tolson, JM Simpson, KN Pham, SV Albright, J
Citation: Ja. Mauskopf et al., Impact of zidovudine-based triple combination therapy on an AIDS Drug Assistance Program, J ACQ IMM D, 23(4), 2000, pp. 302-313
Potential savings in the cost of caring for Alzheimer's disease treatment with rivastigmine - Reply
Authors: Hauber, AB Mauskopf, JA Snyder, EH
Citation: Ab. Hauber et al., Potential savings in the cost of caring for Alzheimer's disease treatment with rivastigmine - Reply, PHARMACOECO, 18(6), 2000, pp. 610-612
Cost-effectiveness model of cytomegalovirus management strategies in renaltransplantation - Comparing valaciclovir prophylaxis with current practice
Authors: Mauskopf, JA Richter, A Annemans, L Maclaine, G
Citation: Ja. Mauskopf et al., Cost-effectiveness model of cytomegalovirus management strategies in renaltransplantation - Comparing valaciclovir prophylaxis with current practice, PHARMACOECO, 18(3), 2000, pp. 239-251
Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in Australia
Authors: Mauskopf, JA Cates, SC Griffin, AD Neighbors, DM Lamb, SC Rutherford, C
Citation: Ja. Mauskopf et al., Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in Australia, PHARMACOECO, 17(6), 2000, pp. 611-620
Potential savings in the cost of caring for Alzheimer's disease - Treatment with rivastigmine
Authors: Hauber, AB Gnanasakthy, A Snyder, EH Bala, MV Richter, A Mauskopf, JA
Citation: Ab. Hauber et al., Potential savings in the cost of caring for Alzheimer's disease - Treatment with rivastigmine, PHARMACOECO, 17(4), 2000, pp. 351-360
Assessing the Saskatchewan database for outcomes research studies of depression and its treatment
Authors: West, SL Richter, A Melfi, CA McNutt, M Nennstiel, ME Mauskopf, JA
Citation: Sl. West et al., Assessing the Saskatchewan database for outcomes research studies of depression and its treatment, J CLIN EPID, 53(8), 2000, pp. 823-831
Savings in the cost of caring for patients with Alzheimer's disease in Canada: An analysis of treatment with rivastigmine
Authors: Hauber, AB Gnanasakthy, A Mauskopf, JA
Citation: Ab. Hauber et al., Savings in the cost of caring for patients with Alzheimer's disease in Canada: An analysis of treatment with rivastigmine, CLIN THER, 22(4), 2000, pp. 439-451
A pharmacoeconomic model for the treatment of influenza
Authors: Mauskopf, JA Cates, SC Griffin, AD
Citation: Ja. Mauskopf et al., A pharmacoeconomic model for the treatment of influenza, PHARMACOECO, 16, 1999, pp. 73-84
Willingness to pay as a measure of health benefits
Authors: Bala, MV Mauskopf, JA Wood, LL
Citation: Mv. Bala et al., Willingness to pay as a measure of health benefits, PHARMACOECO, 15(1), 1999, pp. 9-18
Annual health outcomes and treatment costs for schizophrenia populations
Authors: Mauskopf, JA David, K Grainger, DL Gibson, PJ
Citation: Ja. Mauskopf et al., Annual health outcomes and treatment costs for schizophrenia populations, J CLIN PSY, 60, 1999, pp. 14-19
Risultati: 1-10 |